Point72 (DIFC)’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$39.9M Buy
408,664
+262,364
+179% +$27.2M 2.61% 4
2025
Q2
$15.7M Sell
146,300
-43,665
-23% -$4.42M 0.59% 24
2025
Q1
$19.2M Buy
189,965
+173,529
+1,056% +$17.5M 0.79% 8
2024
Q4
$1.47M Buy
+16,436
New +$1.45M 0.05% 404

Other funds holding BSX

Point72 (DIFC)'s BSX Position: Q3 2025 in Review

Point72 (DIFC) increased its Boston Scientific (BSX) stake by 179% in Q3 2025, buying an estimated $27.2M and bringing the position to 408,664 shares worth $39.9M. The position accounts for 2.61% of the portfolio, ranked #4.

Point72 (DIFC) first reported a position in BSX in Q4 2024 and has held it in 4 quarters since. 1,709 funds tracked by Wall St. Rank hold BSX as of Q3 2025.

  • Point72 (DIFC) held 408,664 shares of Boston Scientific worth $39.9M as of Q3 2025.
  • Point72 (DIFC) bought 262,364 Boston Scientific shares in Q3 2025, an estimated $27.2M.
  • Boston Scientific made up 2.61% of Point72 (DIFC)'s portfolio in Q3 2025, its #4 holding.
  • Point72 (DIFC) first reported a position in Boston Scientific in Q4 2024 and has held it in 4 quarters since.
  • 1,709 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2025.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.